Home » Topics » Disease categories and therapies » Immune

Immune
RSS

VaxGen discontinues development of recombinant anthrax vaccine

May 28, 2007

Novel immunosuppressants disclosed by Sankyo

May 28, 2007

Ty-800 typhoid vaccine shows clinical potential

May 22, 2007

FDA Advisory Committee votes in favor of ACAM-2000

May 22, 2007

DelSite obtains license to NIH technology for typhoid vaccine

May 21, 2007

Y's Therapeutics advances YSPSL to phase II trials for I/R injury

May 21, 2007

Safety and immunogenicity of new oral vaccine against enterotoxigenic E. coli demonstrated in humans

May 18, 2007

Immunosuppression: induction therapy with alemtuzumab

May 14, 2007

Novel preclinical data on immunosuppression presented at the American Transplant Congress

May 11, 2007

Calcineurin inhibitor-free regimen with CP-690550 effective in renal transplantation

May 10, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...